UK - AstraZeneca has dropped plans to sue Merrill Lynch Investment Managers over poor investment performance for its pension fund.
A spokesman for the pharmaceutical giant said the decision was made following advice from both its internal and external counsel. No other details were disclosed. However, MLIM, which made an ou...
To continue reading this article...
Join Professional Pensions
- Unlimited access to real-time news, analysis and opinion from the industry
- Receive our in-depth monthly magazine in either print or digital format
- Access our Sustainable Investment Hub covering news and opinion from thought leaders in the ESG space
- Receive important and breaking news stories selected by the Editors in our daily newsletter
- Hear from industry experts and other forward-thinking leaders
- Receive a monthly members-only newsletter with exclusive opinion pieces from leading industry experts and a feature from the magazine in advance of its release date